Maravai Lifesciences Holdings, Inc.
(NASDAQ : MRVI)

( )
MRVI PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Commercial Services » Miscellaneous Commercial Services
symbolcompany%chnglast%shortavg$volume
ETSYEtsy, Inc. -8.20%74.047.5%$304.41m
EFXEquifax, Inc. -2.91%179.552.0%$149.29m
CPRTCopart, Inc. -3.03%108.854.4%$134.07m
FLTFLEETCOR Technologies, Inc. -3.21%211.733.8%$132.32m
CRLCharles River Laboratories International, Inc. -3.42%217.784.4%$110.46m
BAHBooz Allen Hamilton Holding Corp. -1.22%87.632.1%$91.05m
CLVTClarivate Plc -4.39%14.040.0%$74.01m
CHGGChegg, Inc. -5.61%18.3415.1%$59.33m
MEDPMedpace Holdings, Inc. -3.13%148.881.0%$55.65m
TAXLiberty Tax, Inc. Class A -0.88%37.162.5%$50.66m
TALTAL Education Group -1.03%4.810.6%$49.34m
GGenpact Ltd. -1.90%42.307.1%$48.51m
FOURShift4 Payments, Inc. -4.56%35.790.0%$48.47m
FCNFTI Consulting, Inc. -1.29%172.105.8%$47.21m
WEWeWork, Inc. -7.83%5.530.0%$45.74m

Company Profile

Maravai Lifesciences Holdings, Inc. is a life sciences company. It is engaged in providing products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. The firm operates through the following segments: Nucleic Acid Production, Biologics Safety Testing, and Protein Detection. The Nucleic Acid Production segment focuses on the manufacturing and sale of highly modified nucleic acids products to support the needs of customers’ research, therapeutic and vaccine programs. The Biologics Safety Testing segment focuses on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing activities. The Protein Detection segment is engaged in manufacturing and selling labeling and visual detection reagents to scientific research customers for their tissue-based protein detection and characterization needs. The company was founded by Eric Tardif and Carl W. Hull in March 2014 and is headquartered in San Diego, CA.